Orca-T Continues to Break New Ground in Hematologic Cancers - OncLive

Samer Srour, MD, discusses his experiences with the Orca-T and Orca-Q programs, and highlights how this type of treatment is shifting the field of hematologic malignancies.

Orca-T, a cell therapy product that has demonstrated encouraging efficacy in patients with hematologic cancers as it relates to graft-vs-host disease (GVHD), relapse-free survival (RFS) and overall s… [+10215 chars]

full article...